Back
Hennes & Mauritz AB Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
44
HMRZF
Hennes & Mauritz AB
Last Price:
14.81
Seasonality Move:
-2.85%
Sell
1
AGIO
Agios Pharmaceuticals
Last Price:
38.22
Seasonality Move:
12.89%
Sell
44
Hennes & Mauritz AB (HMRZF)
is a Sell
Is Hennes & Mauritz AB a Buy, Sell or Hold?
- The current Hennes & Mauritz AB [HMRZF] share price is $14.81. The Score for HMRZF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- HMRZF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.17. The Score for AGIO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
HMRZF Stock Price Chart
What is Hennes & Mauritz AB's stock price today?
-
The Hennes & Mauritz AB share price today is $14.81
The current trend is relatively stagnant and HMRZF is experiencing slight buying pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
HMRZF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 48.07 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.26 - 14.82) | Buy |
Bollinger Bands (100): | (14.57 - 16.97) | Sell |
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.34 | Sell |
Relative Strength Index (14 RSI): | 26.34 | Sell |
Chaikin Money Flow: | -1550643 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.73 - 60.93) | Sell |
Bollinger Bands (100): | (42.01 - 53.19) | Sell |
HMRZF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.73 | Buy |
20-day SMA: | 14.55 | Buy |
50-day SMA: | 15.52 | Sell |
200-day SMA: | 15.79 | Sell |
8-day EMA: | 14.74 | Buy |
20-day EMA: | 14.75 | Buy |
50-day EMA: | 15.21 | Sell |
200-day EMA: | 15.67 | Sell |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.89 | Sell |
20-day SMA: | 54.55 | Sell |
50-day SMA: | 49.66 | Sell |
200-day SMA: | 41.9 | Sell |
8-day EMA: | 48.9 | Sell |
20-day EMA: | 52.35 | Sell |
50-day EMA: | 50.92 | Sell |
200-day EMA: | 42.82 | Sell |
Hennes & Mauritz AB Earnings Growth & HMRZF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
Hennes & Mauritz AB Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agios Pharmaceuticals Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |